CDMO Avid Bioservices Inc: Net earnings per share for the last four quarters

Avid Bioservices, Inc. (CDMO) generates a steady cash flow driven by long-term B2B contracts for the production of biologics. The year-over-year EPS (TTM) change on this chart at GURU.Markets reflects profit dynamics, where -109.90 captures the current value of the metric. Experienced management is effectively scaling capacity, while a strong team of specialized engineers and chemists ensures high-quality manufacturing processes.
Financial and market metric breakdowns for Avid Bioservices, Inc. (CDMO)

This indicator measures the dynamics of the trailing twelve-month (TTM) net income per share relative to the previous year. Analyzing the annual EPS (TTM) growth statistics allows for an assessment of the business's actual resilience and the timely identification of fading growth drivers. A positive trend confirms effective capital management and profit scaling. For Avid Bioservices, Inc. (CDMO), this metric depends directly on the volume of long-term B2B contracts. Consistent fulfillment of antibody and vaccine production orders provides fundamental support for earnings.